Abingworth
Emily Janvey joined Abingworth in April 2023 as a Managing Director based in their Boston office. Emily focusses on Abingworth’s Clinical Co-Development practice where she is responsible for sourcing and the execution of deals.
Previously, Emily was Health Care Sector Head within the Investment Strategy Group at ICONIQ and prior to joining ICONIQ, was a Director on KKR’s America’s Health Care Private Equity team investing across the health care landscape and with a focus on large cap private equity, growth equity and non-dilutive financings. Emily was previously a VP at Sixth Street Partners where she provided alternative financing to pharma and biotech. Emily started her career as a consultant in the health care practice at McKinsey and Company.
Emily has served on the boards of companies across healthcare sectors and stages. Emily earned her MD and MBA from the University of Pennsylvania and her BA in neuroscience from Hamilton College.
This person is not in any teams
This person is not in any offices
Abingworth
1 followers
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences sectors. Supporting its portfolio companies with a team of 25 at offices in London, Menlo Park, and Boston, Abingworth has invested in 151 life science companies, completed 65 IPOs and 42 mergers and acquisitions.